LONDONÂ and NEW YORK Â , May 12, 2021 /PRNewswire/ --Â Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately $130 million. The investment will scale Huma's modular platform which can power digital 'hospitals at home' nationally, and support the pharmaceutical and research industries to run the largest ever decentralized clinical trials. Huma's platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive care and research. Leaps by Bayer and Hitachi Ventures led the Series C funding rou...